Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

150%

3 of 2 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04420702Not ApplicableRecruiting

Diffusion Basis Spectrum Imaging of the Prostate

Role: collaborator

NCT01732120Not ApplicableCompleted

Off Clamp Randomization

Role: collaborator

NCT02577146Not ApplicableCompleted

The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic

Role: collaborator

NCT00851682Not ApplicableTerminated

Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma

Role: collaborator

All 4 trials loaded